11-30233736-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001382289.1(FSHB):c.326G>C(p.Ser109Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S109R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001382289.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FSHB | NM_001382289.1 | c.326G>C | p.Ser109Thr | missense_variant | 3/3 | ENST00000533718.2 | |
ARL14EP-DT | XR_007062639.1 | n.351+83154C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FSHB | ENST00000533718.2 | c.326G>C | p.Ser109Thr | missense_variant | 3/3 | 1 | NM_001382289.1 | P1 | |
ARL14EP-DT | ENST00000662729.1 | n.293-76883C>G | intron_variant, non_coding_transcript_variant | ||||||
FSHB | ENST00000254122.8 | c.326G>C | p.Ser109Thr | missense_variant | 3/3 | 5 | P1 | ||
FSHB | ENST00000417547.1 | c.326G>C | p.Ser109Thr | missense_variant | 3/3 | 5 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2023 | The c.326G>C (p.S109T) alteration is located in exon 3 (coding exon 2) of the FSHB gene. This alteration results from a G to C substitution at nucleotide position 326, causing the serine (S) at amino acid position 109 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at